Most Read Articles
01 Jan 2015
Ginkgo biloba has been shown to improve cognitive as well as neuropsychiatric symptoms (NPS) in patients with Alzheimer’s disease (AD) and mixed dementia. During a Schwabe-sponsored symposium last 20 October 2014 held at the University of Malaya in Malaysia, Professor Serge Gauthier of the McGill Centre for Studies in Aging in Quebec, Canada, and Dr Robert Hoerr of the Dr Willmar Schwabe GmbH & Co. KG in Germany, discussed studies that support the safety and efficacy of Ginkgo biloba extract (EGb 761®) in patients with AD and dementia.
26 Aug 2017
Elderly individuals with high levels of serum uric acid may be at an increased risk of dementia, particularly vascular or mixed dementia, a study suggests.
Elvira Manzano, 01 Feb 2014

There is no benefit to using ibuprofen over paracetamol in most patients with upper respiratory tract infections (URTIs). Steam inhalation therapy also does not offer any advantage, research has shown.

Dr. Joseph Delano Fule Robles, 01 Mar 2017

The tau and Aβ amyloid pathways have emerged as possible novel targets in treating Alzheimer’s disease (AD), according to studies discussed at the recently concluded Hong Kong Pharmacy Conference.

Hyperbaric oxygen improves anxiety, nerve function after incomplete spinal cord injury

16 Aug 2017

Hyperbaric oxygen (HBO) improves nerve function, daily function, depression and anxiety in patients with incomplete spinal cord injury (ISCI), a recent study has shown.

Investigators divided 60 patients receiving rehabilitative treatments into three: those who received HBO (n=20), those who received psychotherapy (n=20) and controls who received conventional rehabilitation (n=20).

All patients received medications to improve circulation and promote nerve repair. Those in the psychotherapy group received additional supportive cognitive behavioural therapy. Those in the HBO group received HBO once a day for 6 days a week.

Over 8 weeks, patients in both psychotherapy and HBO groups scored significantly lower in the Hamilton Depression scale (HAMD) compared with controls (p<0.05). There was no significant difference in HAMD scores between the HBO and psychotherapy groups.

Similarly, Hamilton Anxiety (HAMA) scores were significantly lower in both HBO and psychotherapy groups compared with the control group (p<0.05). There was also no significant difference in HAMA scores between HBO and psychotherapy groups.

After the 8-week programme, scores in the American Spinal Injury Association (ASIA) and Functional Independence Measure (FIM) scales were significantly higher in the HBO group than in the psychotherapy and control group (p<0.05).

ASIA and FIM scores were significantly higher in the psychotherapy group than in controls (p<0.05).

“HBO can significantly relieve depression and anxiety, and improve physical function and [activities of daily living) in the patients with ISCI,” said researchers.

“However, we did not calculate sample size because the sample was small, and follow-up only lasted 8 weeks in this study. Therefore, it is necessary to collect more samples and prolong follow-up time,” they added.

Editor's Recommendations
Most Read Articles
01 Jan 2015
Ginkgo biloba has been shown to improve cognitive as well as neuropsychiatric symptoms (NPS) in patients with Alzheimer’s disease (AD) and mixed dementia. During a Schwabe-sponsored symposium last 20 October 2014 held at the University of Malaya in Malaysia, Professor Serge Gauthier of the McGill Centre for Studies in Aging in Quebec, Canada, and Dr Robert Hoerr of the Dr Willmar Schwabe GmbH & Co. KG in Germany, discussed studies that support the safety and efficacy of Ginkgo biloba extract (EGb 761®) in patients with AD and dementia.
26 Aug 2017
Elderly individuals with high levels of serum uric acid may be at an increased risk of dementia, particularly vascular or mixed dementia, a study suggests.
Elvira Manzano, 01 Feb 2014

There is no benefit to using ibuprofen over paracetamol in most patients with upper respiratory tract infections (URTIs). Steam inhalation therapy also does not offer any advantage, research has shown.

Dr. Joseph Delano Fule Robles, 01 Mar 2017

The tau and Aβ amyloid pathways have emerged as possible novel targets in treating Alzheimer’s disease (AD), according to studies discussed at the recently concluded Hong Kong Pharmacy Conference.